Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line

Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line
复制标题

DOI:
10.1016/s0002-9440(10)63312-3
复制
发表时间:
2004-08-01
影响因子:
6
通讯作者:
Itoh, K
Itoh, K
中科院分区:
医学2区
文献类型:
--
作者:
Nakanishi, H;Yoshioka, K;Itoh, K

文献摘要

被引文献

相似文献

多形性恶性纤维组织细胞瘤。(MFH)偶尔与炎性副肿瘤综合征(PNS)有关。近年来,我们发现白细胞介素6(interleukin-6,IL-6)可能是MFH的一种肿瘤相关因子,参与了MFH的发病机制和临床表现。在局部微环境中,肿瘤诱导的炎症反应可能在促进肿瘤进展中发挥作用。为了阐明IL-6在MFH中的生物学相关性,我们建立了一种人MFH细胞系,命名为MIPS-2,来源于PNS患者的切除标本。在该患者中,血清IL-6水平与病程平行:血清IL-6浓度升高在根治性手术后立即恢复正常,肿瘤复发时再升高。MIPS-2表现为多形性外观,严重的核异常,核仁突出,并在裸鼠体内成瘤。MIPS-2表达IL-6、IL-6受体(IL-6 R)和糖蛋白130(gp 130),但缺乏可溶性形式的IL-6 R(sIL-6 R),如通过流式细胞术和逆转录聚合酶链反应分析所确定的。用IL-6和外源性sIL-6 R联合刺激MIPS-2可诱导信号转导和转录激活因子3(STAT 3)和丝裂原活化蛋白激酶(MAPK)磷酸化,降低细胞增殖,减弱侵袭力,并诱导形态学改变。这些结果提示IL-6/sIL-6 R信号通路通过STAT 3和MAPK通路以自分泌和/或旁分泌的方式在MFH的增殖、侵袭和形态学中起着关键作用,并提出了使用抗生长因子和促炎性丝氨酸靶向策略来对抗破坏性MFH的治疗潜力。
Pleomorphic malignant fibrous histiocytoma. (MFH) is occasionally associated with inflammatory paraneoplastic syndrome (PNS). Recently, we reported that interleukin (IL)-6, one of the candidate cytokines, which induces such systemic inflammatory reaction, may be a tumor-associated factor involved in the pathogenesis and its clinical manifestations of MFH. In the local microenvironment, tumor-induced inflammatory reaction may play a role favoring tumor progression. To clarify the biological relevance of IL-6 in MFH, we established a human MFH cell line, named MIPS-2, derived from a resected specimen of a patient presenting with PNS. In this patient, the serum IL-6 level ran parallel to the disease course: elevated serum IL-6 concentration normalized immediately after radical surgery, and re-elevation occurred on tumor recurrence. MIPS-2 presented pleomorphic appearance, severe nuclear abnormalities with prominent nucleoli, and tumorigenesis in nude mice. MIPS-2 expressed IL-6, IL-6 receptor (IL-6R), and glycoprotein 130 (gp130) but lacked the soluble form of IL-6R (sIL-6R), as determined by flow cytometry and reverse transcriptase-polymerase chain reaction analyses. Stimulation of MIPS-2 with IL-6 combined with exogenous sIL-6R induced phosphorylation of both signal transducer and activator of transcription 3 (STAT3) and mitogen-activated protein kinase (MAPK), decreased cell proliferation, attenuated invasion, and induced morphological changes. Collectively, these data suggested that the IL-6/sIL-6R signaling pathway plays a pivotal role for proliferation, invasion, and morphology of MFH via STAT3 and MAPK pathway as autocrine and/or paracrine manner, and proposed the therapeutic potential for the use of both anti-growth factor and proinflammatory cytokine-targeting strategies to combat devastating MFH.